global public health - Publications - Faculty & Research - Harvard Business School

Filter Results: (2,068)

Filter Results: (2,068)

Show Results For

← Page 19 of 2,068 Results →

Sort by

Are you looking for?

→Search All HBS Web

January 2018 (Revised March 2018)
Case

Wenzhou Kangning Hospital: Changing Mental Healthcare in China

By: William C. Kirby, Wei Zhang, Yuanzhuo Wang and Nancy Hua Dai

The city of Wenzhou in the Province of Zhejiang, long known in China for entrepreneurship, now hosts the country’s largest privately owned mental health hospital group. This case traces the development of Wenzhou Kangning Hospital Co, Ltd. from founding to just before... View Details

Keywords: Mental Health; Hospital; IPO; China; Zhejiang; Wenzhou; Private Healthcare; Private Hospital; Health Care and Treatment; Private Ownership; Corporate Governance; Growth and Development; Entrepreneurship; Health Industry; China

June 2015 (Revised November 2016)
Supplement

HealthCare.gov: The Crash and the Fix (B)

By: Leonard A. Schlesinger and Paras D. Bhayani

A review of the process utilized by the Obama administration to create the Health Care.gov exchange and the problems that resulted from the implementation effort. This case provides the follow on strategy and processes utilized to get the site up and running after the... View Details

Keywords: Organizational Change; Implementing Strategy; Implementation; Government Innovation; Health Care Industry; Health Care Reform; Service Delivery; Internet and the Web; Health; Government and Politics; Public Administration Industry; Public Administration Industry; Public Administration Industry; United States

February 2015 (Revised November 2015)
Supplement

Building an Integrated Biopharma Company: Crucell (B)

By: Richard G. Hamermesh, Marianne Van Der Steen and Susan Harmeling

The Crucell (B) case updates events at Crucell since 2009. In September, 2009, Johnson & Johnson acquired 18% of Crucell for $400 million. This investment was part of a business development deal. Subsequently, in 2012, Johnson & Johnson acquired Crucell for $2.8... View Details

Keywords: Biotechnology; Biopharmacy Company; Licensing Agreements In Biopharmacy; Licensing; Human Cell-line Technology; Vaccine; Healthcare Innovation; Global Health; Entrepreneurship; Health Care and Treatment; Acquisition; Innovation and Invention; Biotechnology Industry; Pharmaceutical Industry

May 2015 (Revised May 2017)
Case

Colgate-Palmolive Company: Marketing Anti-Cavity Toothpaste

By: John A. Quelch and Margaret L. Rodriguez

In October 2013, Colgate-Palmolive Company, the world's leading oral care company, was about to launch its new Colgate® Maximum Cavity Protection™ plus Sugar Acid Neutralizer™ toothpaste in Brazil. Oral care category accounted for 46 percent of Colgate's $17.4 billion... View Details

Keywords: New Product Management; Consumer Segmentation; Global Marketing; Corporate Social Responsibility; Healthcare; Sustainability; Health Care and Treatment; Environmental Sustainability; Marketing; Segmentation; Product Development; Product Launch; Corporate Social Responsibility and Impact; Product Positioning; Consumer Products Industry; Brazil; United States

May 2009
Teaching Note

The World Food Programme during the Global Food Crisis (TN) (A) and (B)

By: Eric D. Werker

Teaching Note for [709024] and [709052]. View Details

Keywords: Non-Governmental Organizations; Nutrition; Food; Crisis Management; Problems and Challenges; Poverty

October 2019 (Revised December 2019)
Case

La Roche-Posay: Growing L'Oreal's Active Cosmetics Brand

By: Jill Avery, Vincent Dessain and Mette Fuglsang Hjortshoej

As 2018 neared its end, Laetitia Toupet, international general manager of L’Oréal’s La Roche-Posay brand reflected on the brand’s achievements over the past year. At €1 billion in revenue, La Roche-Posay had recently become the number one dermocosmetics brand in the... View Details

September–October 2020
Article

Global Supply Chains in a Post-Pandemic World: Companies Need to Make Their Networks More Resilient. Here's How.

By: Willy C. Shih

The COVID-19 pandemic exposed the vulnerabilities in the production strategies and supply chains of firms everywhere. Coupled with a rise in economic nationalism, manufacturers everywhere are going to be under pressure to rethink their sourcing and logistics... View Details

Keywords: Resilience; Pandemic; Operations Management; Health Pandemics; Supply Chain; Supply Chain Management; Manufacturing Industry; United States; Asia; Europe

Find at Harvard

Register to Read

24 Oct 2014
Working Paper Summaries

Individual Experience of Positive and Negative Growth Is Asymmetric: Global Evidence from Subjective Well-being Data

Keywords: by Jan-Emmanuel De Neve, George W. Ward, Femke De Keulenaer, Bert Van Landeghem, Georgios Kavetsos & Michael I. Norton

October 2021 (Revised May 2023)
Case

Engine No.1: An Impact Investing Firm Engages with ExxonMobil

By: Mark Kramer, Shawn Cole, Vikram S. Gandhi and T. Robert Zochowski

ExxonMobil, the world's fifth largest source of carbon emissions, remained committed to aggressively expanding its oil & gas business despite global warming. During the COVID pandemic this strategy resulted in massive losses as the price and demand for oil declined. ... View Details

Keywords: Carbon Emissions; Global Warming; Impact Investment Funds; Hedge Fund Activism; Leadership Development; Business Model; Renewable Energy; Resource Allocation; Decision Choices and Conditions; Governing and Advisory Boards

23 Jun 2020
Working Paper Summaries

Dignity, Inequality, and the Populist Backlash: Lessons from America and Europe for a Sustainable Globalization

Keywords: by Rawi Abdelal

February 2015 (Revised November 2015)
Case

Building an Integrated Biopharma Company: Crucell (A)

By: Richard G. Hamermesh, Marianne Van Der Steen and Susan S. Harmeling

By 2009, Crucell had become the largest biopharma company in the Netherlands and a symbol of national pride. The case traces the evolution of the company from a University spin-off into a fully-integrated company. Crucell's success, particularly in the vaccine space,... View Details

Keywords: Biotechnology; Biopharmacy Company; Licensing; Licensing Agreements In Biopharmacy; Human Cell-line Technology; Vaccine; Healthcare Innovation; Global Health; Partners and Partnerships; Entrepreneurship; Growth and Development Strategy; Biotechnology Industry; Pharmaceutical Industry; Netherlands

September 2020
Article

Regulatory Sandboxes: A Cure for mHealth Pilotitis?

By: Abhishek Bhatia, Rahul Matthan, Tarun Khanna and Satchit Balsari

Mobile health (mHealth) and related digital health interventions in the past decade have not always scaled globally as anticipated earlier despite large investments by governments and philanthropic foundations. The implementation of digital health tools has suffered... View Details

Keywords: COVID-19; mHealth; Digital Health; Design Thinking; Regulation; Intervention; Regulatory Sandbox; Health Care and Treatment; Technological Innovation; Design; Governing Rules, Regulations, and Reforms; India

January 2021
Article

State and Local Government Employment in the COVID-19 Crisis

By: Daniel Green and Erik Loualiche

Local governments are facing large losses in revenues and increased expenditures because of the COVID-19 crisis. We document a causal relationship between fiscal pressures induced by COVID-19 and the layoffs of state and local government workers. States that depend... View Details

Keywords: Local Government; Municipal Finance; Public Finance; Fiscal Capacity; Fiscal Policy; Governance; Local Range; Health Pandemics; Employment; Finance; Policy; Public Sector

November 2013 (Revised January 2015)
Case

Obamacare

By: Matthew Weinzierl and Katrina Flanagan

One vote in June, 2012, decided the fate of President Barack Obama's crowning first-term achievement: universal health insurance. Chief Justice John Roberts of the U.S. Supreme Court cast the deciding vote to uphold the keystone of the reform: the mandate to purchase... View Details

Keywords: Universal Health Insurance; Adverse Selection; Leviathan; Courts and Trials; Judgments; Insurance; Health Care and Treatment; Government and Politics; Public Administration Industry; Public Administration Industry; Public Administration Industry; United States

May 2014 (Revised March 2017)
Case

Unilever's Lifebuoy in India: Implementing the Sustainability Plan

By: Christopher A. Bartlett

Unilever's new Global Brand VP must not only revitalize Lifebuoy soap's sagging market performance, but simultaneously impact the health of one billion people worldwide. The latter challenge comes from Unilever's new CEO who has introduced the Unilever Sustainable... View Details

Keywords: Multinational Management; Corporate Social Responsibility; Strategy Implementation; Marketing Strategy; Mission And Purpose; Change Management; International Business; Global; Fast-moving Consumer Goods; Soap; Corporate Social Responsibility and Impact; Health Care and Treatment; Environmental Sustainability; Global Strategy; Developing Countries and Economies; Beauty and Cosmetics Industry; Health Industry; India

2013
Other Unpublished Work

NHS and Social Care Workforce: Meeting Our Needs Now and In the Future?

By: Candice Imison and Richard Bohmer

Keywords: Health Care; Work Force Management; Management; Employees; Health Care and Treatment; Public Administration Industry; Public Administration Industry

25 Jul 2023
Research & Ideas

Could a Business Model Help Big Pharma Save Lives and Profit?

cross-sector and cross-border partnerships needed to execute the model. Adding new information about how pharmaceutical companies handle global public health challenges.... View Details

Keywords: by Esther Schrader; Health; Health

November 2012
Case

CSIRO: The Light Metals Flagship Decision

By: Willy Shih, Margaret P. Pierson and Dawn Lau

This case explores the challenge of investing in basic research as a public good. CSIRO was Australia's leading science and research agency, and it was chartered to enhance national prosperity through R&D. Its Flagships program was designed to align research interests... View Details

October 2018 (Revised September 2020)
Case

Testing Autonomy in Pittsburgh

By: Mitchell Weiss and Brittany Urick

Pittsburgh’s mayor had been among the first to welcome self-driving vehicles but was now one of many needing to react after a pedestrian fatality involving an autonomous Uber in Arizona. He had originally preferred to roll out “the red carpet” instead of the “red... View Details

December 2020
Article

Multinational Firms and the Politics of International Trade in Multidisciplinary Perspective

By: Grace A. Ballor and Aydin B. Yildirim

From the technical analyses of wide ranges of scholars to the public discourse backlashes against globalization, there is a huge volume of work historicizing, quantifying, and problematizing the complex role of multinational corporations (MNCs) in international trade.... View Details

Keywords: Multinational Corporations; International Trade; Big Business; Economic Governance; Global Value Chains; Trade Policy; Corporate Regulation; Multinational Firms and Management; Trade; Policy; Governance; Globalization

Find at Harvard

←
19
20
…
103
104
→